Kenneth Perego II - Jul 25, 2024 Form 4 Insider Report for One World Products, Inc. (OWPC)

Role
Director
Signature
/s/ Dr. Kenneth Perego, II, M.D.
Stock symbol
OWPC
Transactions as of
Jul 25, 2024
Transactions value $
$2,250,000,000
Form type
4
Date filed
8/22/2024, 03:57 PM
Previous filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OWPC Common Stock 7M Jul 25, 2024 See footnote F5
holding OWPC Common Stock 5.79M Jul 25, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OWPC Series A Preferred Stock Award $2.25B +15K +0.58% $150,000.00 2.6M Jul 25, 2024 Common Stock 1.5M See footnote F1, F2, F4, F6, F7
transaction OWPC Warrants to Purchase Common Stock Award $0 +1.5M +272.73% $0.00 2.05M Jul 25, 2024 Common Stock 1.5M $0.25 See footnote F1, F3, F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 15,000 shares of Series A Preferred Stock and a Warrant to Purchase Common Stock of the Issuer were purchased, in units, by the Reporting Person for $150,000 in cash. Each share of Series A Preferred Stock is convertible at any time, at the Reporting Person's election, into 100 shares of the Issuer's common stock and has no expiration date
F2 Each share of Series A Preferred Stock is convertible at any time, at the election of the Reporting Person, into 100 shares of common stock of the Issuer.
F3 The Warrant to Purchase Common Stock is exercisable at any time, at the election of the Reporting Person, at an exercise price of $0.25 per share.
F4 Owned of record by Perego Trust, of which the Reporting Person is Trustee.
F5 Owned of record by CB Medical, LLC, of which the Reporting Person is the owner.
F6 All of the purchase price was allocated to the shares of Series A Preferred Stock.
F7 The Reporting Person beneficially owns a total of 17,785,000 shares of common stock of the Issuer.

Remarks:

This is a late Form 4 filing.